Pharmaceuticals

Viral Vector Production (Research-Use) Market Outlook 2026–2035: Growth Drivers and Industry Forecast

February 20, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the viral vector production (research-use) market from 2026–2035 with trusted insights from The Business Research Company

What long-term size projections exist for the Viral Vector Production (Research-Use) Market covering 2026–2035?

The viral vector production (research-use) market has experienced rapid growth in recent years. This market is anticipated to expand from $1.77 billion in 2025 to $2.04 billion in 2026, driven by a compound annual growth rate (CAGR) of 15.2%. Historically, this growth has been attributed to factors such as increased investment in gene therapy research, the expansion of academic and translational research programs, the availability of advanced cell culture technologies, a rising utilization of viral vectors in oncology studies, and the growth of contract research activities.

The viral vector production (research-use) market size is projected to undergo substantial expansion over the next few years. It is forecast to achieve a value of $3.56 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 14.9%. This projected growth throughout the forecast period stems from factors such as increasing demand for advanced gene delivery tools, the growing integration of automation in research laboratories, the broadened scope of CRISPR and gene editing research, an uptick in collaboration between academic institutions and biopharmaceutical firms, and a heightened emphasis on reproducibility and standardization. Prominent trends for the forecast period involve the increasing uptake of scalable viral vector manufacturing platforms, a rising need for high-purity research-grade vectors, the expanding utilization of suspension cell culture systems, the wider deployment of automated upstream and downstream processing, and a stronger focus on vector characterization and quality control.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28350&type=smp

Which Drivers Are Impacting The Competitive Landscape Of The Viral Vector Production (Research-Use) Market?

The growing incidence of genetic disorders is expected to drive the expansion of the viral vector production (research-use) market moving forward. Genetic disorders are illnesses or states resulting from irregularities in an individual’s deoxyribonucleic acid, which can be passed down from one or both parents or arise from new genetic mutations. The increase in genetic disorders is attributed to rising parental age, enhancing the likelihood of genetic mutations being transferred to offspring. The increasing commonness of genetic disorders supports the growth of viral vector production (research-use) by stimulating demand for advanced gene delivery tools to examine disease mechanisms and develop potential therapeutic approaches. For instance, in November 2024, according to the Centers for Disease Control and Prevention (CDC), a US-based government public health agency, Trisomy 21 (Down syndrome) occurs in about 1 in 643 births, resulting in approximately 5,713 new cases annually, and Trisomy 18 occurs in about 1 in 3,336 births, or roughly 1,101 cases yearly. Therefore, the increasing occurrence of genetic disorders is anticipated to propel the growth of the viral vector production (research-use) market.

What Segments Are Identified Within The Structure Of The Viral Vector Production (Research-Use) Market?

The viral vector production (research-use) market covered in this report is segmented –

1) By Type: Adeno-Associated Virus (AAV), Lentivirus, Adenovirus, Retrovirus, Other Types

2) By Production: Transient Transfection, Stable Cell Line, Viral Packaging System, Other Production Methods

3) By Workflow: Upstream Processing, Downstream Processing

4) By Application: Gene Therapy, Vaccines, Oncology, Infectious Diseases, Other Applications

5) By End-Use: Pharmaceutical And Biopharmaceutical Companies, Research Institutes

Subsegments:

1) By Adeno-Associated Virus: Single-Stranded Adeno-Associated Virus, Self-Complementary Adeno-Associated Virus, Hybrid Adeno-Associated Virus

2) By Lentivirus: Human Immunodeficiency Virus-Based Lentivirus, Feline Immunodeficiency Virus-Based Lentivirus, Equine Infectious Anemia Virus-Based Lentivirus

3) By Adenovirus: Replication-Competent Adenovirus, Replication-Deficient Adenovirus, Helper-Dependent Adenovirus

4) By Retrovirus: Gamma Retrovirus, Spumavirus (Foamy Virus), Alpha Retrovirus

5) By Other Types: Herpes Simplex Virus Vectors, Baculovirus Vectors, Sendai Virus Vectors

Which Innovation Trends Are Advancing Developments Within The Viral Vector Production (Research-Use) Market?

Leading companies in the viral vector production market are concentrating on creating sophisticated solutions, including specialized cell culture media, to enhance transfection efficiency, increase viral vector yields, and guarantee consistent quality for research uses. Cell culture media are nourishing solutions formulated to sustain cell growth and maintenance outside their natural habitat. These solutions contain vital elements like amino acids, vitamins, and growth factors, optimized for particular cell types and applications. For example, in January 2023, FUJIFILM Irvine Scientific, a US-based life sciences company, unveiled BalanCD HEK293 Viral Feed, recognized as the world’s first chemically defined nutrient feed specifically optimized for HEK293 suspension cultures employed in AAV viral vector manufacturing. Through this introduction, the company seeks to substantially elevate adeno-associated virus (AAV) yields, demonstrating an improvement of up to 67% in viral packaging efficiency compared to basal media. This feed is engineered for scalable gene therapy and biotech workflows, ensuring reliable performance across different formats and compatibility with various media systems.

Which Key Market Players Are Investing In Expansion And Innovation Within The Viral Vector Production (Research-Use) Market?

Major companies operating in the viral vector production (research-use) market are Sanofi S.A., Thermo Fisher Scientific Inc., Merck KGaA, Becton Dickinson and Company, Lonza Group AG, Sartorius AG, Charles River Laboratories International Inc., FUJIFILM Diosynth Biotechnologies U.S.A. Inc., Curia Inc., AGC Biologics GmbH, SK pharmteco Inc., Oxford Biomedica Plc, Waisman Biomanufacturing, Voyager Therapeutics Inc., FinVector Oy, Batavia Biosciences BV., GENEZEN LABORATORIES, BioNTech IMFS GmbH, VGXI Inc., Tonix Pharmaceuticals, Cell and Gene Therapy Catapult, Mustang Bio Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/viral-vector-production-research-use-global-market-report

Which Regions Are Poised For Strategic Growth In The Viral Vector Production (Research-Use) Market?

North America was the largest region in the virtual vector production (research-use) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the viral vector production (research-use) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Viral Vector Production (Research-Use) Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=28350&type=smp

Browse Through More Reports Similar to the Global Viral Vector Production (Research-Use) Market 2026, By The Business Research Company

Viral Vector Manufacturing Market Report 2026

https://www.thebusinessresearchcompany.com/report/viral-vector-manufacturing-global-market-report

Viral And Non Viral Vector Manufacturing Market Report 2026

https://www.thebusinessresearchcompany.com/report/viral-and-non-viral-vector-manufacturing-global-market-report

Oral Expectorant Market Report 2026

https://www.thebusinessresearchcompany.com/report/oral-expectorant-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795